Daniela E Oprea-Lager
Overview
Explore the profile of Daniela E Oprea-Lager including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Donswijk M, Ettema R, van der Gaag S, Wondergem M, Cheung Z, van der Poel H, et al.
EJNMMI Res
. 2024 Oct;
14(1):99.
PMID: 39446290
No abstract available.
12.
van Altena E, Jansen B, Korbee M, Knol R, Luining W, Nieuwenhuijzen J, et al.
Eur Urol Oncol
. 2024 Oct;
PMID: 39414419
Background And Objective: Biochemical recurrence (BCR) of prostate cancer (PCa) after curative radiotherapy (RT) is defined according to the Phoenix criteria, which is a prostate-specific antigen (PSA) rise of ≥2.0 ...
13.
Wijngaarden J, Slebe M, Pouw J, Oprea-Lager D, Schuit R, Dickhoff C, et al.
Eur J Nucl Med Mol Imaging
. 2024 Oct;
52(2):719-729.
PMID: 39377810
Introduction: The novel positron emission tomography (PET) imaging tracer, [F]F-AraG, targets activated T-cells, offering a potential means to improve our understanding of immune-oncological processes. The aim of this study was...
14.
Bahce I, Dickhoff C, Schneiders F, Veltman J, Heineman D, Hashemi S, et al.
J Immunother Cancer
. 2024 Sep;
12(9).
PMID: 39349061
Background: In non-small cell lung cancer (NSCLC), chemoradiotherapy (CRT) yields pathological complete response (pCR) rates of approximately 30%. We investigated using ipilimumab plus nivolumab (IPI-NIVO) with neoadjuvant CRT in resectable,...
15.
Hagens M, Luining W, Boeve L, Knol R, Roeleveld T, Srbljin S, et al.
Prostate Cancer Prostatic Dis
. 2024 Sep;
PMID: 39313655
Background/objectives: This study reassesses the diagnostic value of PSMA PET/CT in unfavorable intermediate-risk prostate cancer (PCa) and validates the Prostate Cancer Network the Netherlands (PCNN) subclassification. Subjects/methods: Men subjected to...
16.
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics
Roberts M, Papa N, Veerman H, de Bie K, Morton A, Franklin A, et al.
BJU Int
. 2024 Sep;
134 Suppl 2:47-55.
PMID: 39262180
Objectives: To construct and externally calibrate a predictive model for early biochemical recurrence (BCR) after radical prostatectomy (RP) incorporating clinical and modern imaging characteristics of the primary tumour. Patients And...
17.
Luining W, Boeve L, Hagens M, Meijer D, de Weijer T, Ettema R, et al.
Eur Urol Oncol
. 2024 May;
PMID: 38693019
Background: Various risk classification systems (RCSs) are used globally to stratify newly diagnosed patients with prostate cancer (PCa) into prognostic groups. Objective: To compare the predictive value of different prognostic...
18.
Tilki D, van den Bergh R, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al.
Eur Urol
. 2024 Apr;
86(2):164-182.
PMID: 38688773
Background And Objective: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International...
19.
Hagens M, van Leeuwen P, Wondergem M, Boellaard T, Sanguedolce F, Oprea-Lager D, et al.
J Nucl Med
. 2024 Apr;
65(6):888-896.
PMID: 38637140
In contemporary oncologic diagnostics, molecular imaging modalities are pivotal for precise local and metastatic staging. Recent studies identified fibroblast activation protein as a promising target for molecular imaging across various...
20.
Cornford P, van den Bergh R, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al.
Eur Urol
. 2024 Apr;
86(2):148-163.
PMID: 38614820
Background And Objective: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International...